UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:July 13,
Cymabay Therapeutics (NASDAQ:CBAY)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Cymabay Therapeutics Charts.
Cymabay Therapeutics (NASDAQ:CBAY)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Cymabay Therapeutics Charts.

Cymabay Therapeutics, Inc. News

Gilead Sciences Announces Completion of Acquisition of CymaBay
Friday 22 March 2024 (1 month ago) • Business Wire
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 14D9 - Solicitation, recommendation statements
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC14D9C - Written communication relating to third party tender offer
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)

More Cymabay Therapeutics, Inc. News Articles